The Patent Finder

JCR Pharmaceuticals Co., Ltd.

38 patents currently held · Updated Nov 17, 2026
8 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Recorded under 3 name spellings.

4
Ending by 2030
Dec 2026
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 2 fees due Feb 20 to 28, 2027 · next Feb 20
  • 1 fee due Jul 21, 2027
    The maintenance fee for Methods and Compositions for Increasing N-Acetylglucosaminidase Activity in the CNS (US 10,538,589) comes due Jul 21, 2027. Unpaid by Jan 21, 2028, it lapses early.
  • 1 fee due Aug 11, 2027
    The maintenance fee for Medium Containing Uridine and N-Acetyl-D-Mannosamine (US 10,557,115) comes due Aug 11, 2027. Unpaid by Feb 11, 2028, it lapses early.
  • 4 fees due Sep 8 to 30, 2027 · next Sep 8
  • 1 fee due Oct 16, 2027
    The maintenance fee for Fusion proteins containing a BDNF and an anti-human transferrin receptor antibody (US 11,958,905) comes due Oct 16, 2027. Unpaid by Apr 17, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
PatentTitleStatus Expires Confidence
US 8,299,018Proteins with an Attached Short Peptide of Acidic Amino Acids
In force
 · Medium confidence
In forceMedium confidence
US 7,741,446Fusion Antibodies That Cross the Blood-Brain Barrier in Both Directions
In force
 · High confidence
In forceHigh confidence
US 9,567,400Methods and Compositions for Increasing Alpha-L-Iduronidase Activity in the CNS
In force
 · High confidence
In forceHigh confidence
US 10,202,467Methods and Compositions for Increasing Alpha-L-Iduronidase Activity in the CNS
In force
 · Medium confidence
In forceMedium confidence
US 8,834,874Methods and Compositions for Increasing Iduronate 2-Sulfatase Activity in the CNS
In force
 · High confidence
In forceHigh confidence
US 9,279,109Method for production of recombinant human iduronate 2-sulfatase
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,906,692Instrument and method for analysis of mannose 6-phosphate
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,011,651Methods and Compositions for Increasing Iduronate 2-Sulfatase Activity in the CNS
In force
 · High confidence
In forceHigh confidence
US 8,486,399Methods and Compositions for Increasing Arylsulfatase A Activity in the CNS
In force
 · High confidence
In forceHigh confidence
US 8,920,801Methods and Compositions for Increasing Arylsulfatase a Activity in the CNS
In force
 · High confidence
In forceHigh confidence
10 of 38 patents shown.
Pro members see all 38.
Pro members: see all 38 patents
Also on record, not counted in the 38: 8 patents in force now held by others · 40 lapsed for an unpaid fee · 29 ended at full term · 1 surrendered on reissue. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

14 pending · 8 abandoned · 22 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited